omega-n-methylarginine has been researched along with saralasin in 2 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (saralasin) | Trials (saralasin) | Recent Studies (post-2010) (saralasin) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 1,497 | 13 | 16 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | saralasin (IC50) |
---|---|---|---|
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0006 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0008 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
Blantz, RC; De Nicola, L; Gabbai, FB | 1 |
2 other study(ies) available for omega-n-methylarginine and saralasin
Article | Year |
---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Glomerular Filtration Rate; Glycine; Imidazoles; Kidney Glomerulus; Kidney Tubules; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Saralasin; Tetrazoles | 1992 |